MDXG.US MiMedx Group Inc

Healthcare Biotechnology USA Stocks
3.21 USD
Close of Nov 15, 2026
3.03 7.45
Market cap
USD 468M
P/E
-
P/B
2.22x
ROE
-21.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is MDXG.US undervalued?

Graham number

The Graham number of MiMedx Group Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

MiMedx Group Inc fundamental analysis

No fundamental analysis for MiMedx Group Inc yet.

MiMedx Group Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About MiMedx Group Inc

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs asep…

Full company profile